Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events

dc.contributor.author	Yazici, Y
dc.contributor.author	Yazici, H
dc.date.accessioned	2021-03-03T12:46:09Z
dc.date.available	2021-03-03T12:46:09Z
dc.identifier.citation	Yazici Y., Yazici H., "Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events", Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.504
dc.identifier.other	av_3002d467-ab76-425f-812d-96bf359326a4
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/36761
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	İmmünoloji ve Romatoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ROMATOLOJİ
dc.title	Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	63
dc.contributor.firstauthorID	129963

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.